RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:price being completely controlled held down.QContinuum1 wrote: LABS does not have any late stage trials that will commercialized any time soon. Simply look at the MD&A and LABS tells you all you need to know about that aspect of the business.
If we're waiting for that to happen, we're all going to be waiting a VERY long time.
Exactly especially if you watched the vidio someone posted
a trial costs in the neighborhood of $35 mill
anyone that thinks MPL has over $400 mill of costs in trials is delusional !!
and here is the pr again from whenever:
This is from Medipharm web.
Multiple Randomized Controlled Trials have recently been approved by Health Canada featuring MediPharm products
This means they are using one of MPL's products in the formulation of whatever they are testing ...not it is MPL trial.
in indications such as Depression related sleep disorders, Post surgical pain treatment, and Opioid Sparing in chronic pain
Anyone here knows which product they are, i don't think so, one of the problem with Labs is their I.R. Also a penny stock of $0,08 doesn't really interest the analyst and institution, even the big guys like Aurora, Ogi, Canopy, Tilray aren't interested to come with a buyout at our chesp price. It seems that even if Labs doesn't do good promotion, the buyers who dig into the stock aren't interested either, it is like a mistery. Labs will probably profitable this year but eventhough at that moment we will hit the $0,15 or may be $0,20 by y/e still if they don't promote the company we will be hanging at these level for a while. It seems that managment is sitting and waiting that one of the trial came out with a major impact.
P.S.: the only good thing i can see we have been going sideways for 2 years minimum now, usually the longer we go sideways when it breaks up or down thinks goes quick.